Ignite Creation Date:
2024-05-06 @ 6:51 PM
Last Modification Date:
2024-10-26 @ 2:56 PM
Study NCT ID:
NCT05815485
Status:
RECRUITING
Last Update Posted:
2023-10-31
First Post:
2023-04-13
Brief Title:
A Randomized Double-Blind Placebo-Controlled Phase 23 Study to Determine the Safety and Effectiveness of Azeliragon in the Treatment of Patients Hospitalized for Coronavirus Disease 2019 COVID-19 or Pneumonia
Sponsor:
Salim S Hayek
Organization:
University of Michigan
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-05-04
Start Date Type:
ACTUAL
Primary Completion Date:
2026-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-04
Completion Date Type:
ESTIMATED
First Submit Date:
2023-04-13
First Submit QC Date:
April 13 2023
Study First Post Date:
2023-04-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-27
Last Update Post Date:
2023-10-31
Last Update Post Date Type:
ACTUAL